120
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Adherence to recommended clinical guidelines in extensive disease small-cell lung cancer across the US, Europe, and Japan

, , , &
Pages 355-366 | Published online: 28 Feb 2019

References

  • GovindanRPageNMorgenszternDChanging epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results databaseJ Clin Oncol200624284539454417008692
  • American Cancer SocietyCancer Facts and Figures 2017AtlantaAmerican Cancer Society2017
  • RiazSPLüchtenborgMCouplandVHSpicerJPeakeMDMøllerHTrends in incidence of small cell lung cancer and all lung cancerLung Cancer201275328028421893364
  • KinoshitaFLItoYNakayamaTTrends in lung cancer incidence rates by histological type in 1975–2008: a population-based study in Osaka, JapanJ Epidemiol2016261157958627150013
  • EttingerDSAisnerJChanging face of small-cell lung cancer: real and artifactJ Clin Oncol200624284526452717008688
  • ByersLARudinCMSmall cell lung cancer: where do we go from here?Cancer2015121566467225336398
  • MickePFaldumAMetzTStaging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer – what limits limited disease?Lung Cancer200237327127612234695
  • ChuteJPChenTFeigalESimonRJohnsonBETwenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progressJ Clin Oncol19991761794180110561217
  • SchneiderBJKalemkerianGPPersonalized therapy of small cell lung cancerAdv Exp Med Biol201689014917426703804
  • BecklesMASpiroSGColiceGLRuddRMInitial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromesChest20031231 Suppl97s104s12527569
  • AartsMJAertsJGvan den BorneBEBiesmaBLemmensVEKlooverJSComorbidity in patients with small-cell lung cancer: trends and prognostic impactClin Lung Cancer201516428229125572007
  • KalemkerianGPWooBWAkerlyWNCCN guidelines insights: small cell lung cancer, version 2.2018J Natl Compr Canc Netw2018161171118230323087
  • FruhMde RuysscherDPopatSSmall-cell lung cancer (SCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-upAnn Oncol201324Suppl 6vi99vi10523813929
  • AmarasenaIUChatterjeeSWaltersJAEWood-BakerRFongKMCochrane Lung Cancer GroupPlatinum versus non-platinum chemotherapy regimens for small cell lung cancerCochrane Database Syst Rev2015993CD006849
  • HumeniukMSKelleyMJSecond line treatment of small cell lung cancer: more is better?Ann Transl Med20164Suppl 1S6527868033
  • PostmusPEQuoixEArdizzioniASmall cell lung cancer in daily practice; SCOT registry (small cell lung cancer treatment and outcome)J Thor Oncol201311Suppl 2S339
  • GleesonMDaneseMLubeckDPatterns of systemic treatment in US Medicare patients with extensive disease small cell lung cancerIASLC Chicago Multidisciplinary Symposium in Thoracic OncologyChicago, IL2016
  • SimosDSajjadyGSergiMThird-line chemotherapy in small-cell lung cancer: an international analysisClin Lung Cancer201415211011824365050
  • GueronBKishJKO’DayKMartelMJManley DaumontMPatient count projections for advanced melanoma by line of therapy and other clinical characteristics in EU countries: results from the UK, Germany, France, Italy and Spain (EU-5)Value Health2014177A619
  • DibonaventuraMHigginbottomKMeyersAMorimotoYIlacquaJTreatment pattern differences across the United States, Western Europe, and Japan among patients with metastatic renal cell carcinomaValue Health2016197A764
  • CaldeiraRScazafaveMReal-world treatment patterns for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in Europe and the United StatesOncol Ther20164218919728261649
  • NodaKNishiwakiYKawaharaMIrinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancerN Engl J Med20023462859111784874
  • LaraPNNataleRCrowleyJPhase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124J Clin Oncol200927152530253519349543
  • ParsonsHMHarlanLCStevensJLTreatment of small cell lung cancer in academic and community settings: factors associated with receiving standard therapy and survivalCancer J20142029710424667952